Trial NCT01189253

View at ClinicalTrials.gov 
Org. Study IDs: EORTC-62091
Secondary IDs: 2009-014889-26 EORTC-62091 EU-21059 PMAR-EORTC-62091 SARC-020

Last trial update was posted on 2014-08-08

MeSH Interventions

Doxorubicin Liposomal doxorubicin Trabectedin

MeSH Conditions

Sarcoma

Other Conditions


Stopping Reasons

Results of step1: none of the experimental arms fulfills expectations and the study will not continue as a phase III.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID